96 related articles for article (PubMed ID: 9120411)
1. The halogenated tetrahydro-beta-carboline "TaClo": a progressively-acting neurotoxin.
Heim C; Sontag KH
J Neural Transm Suppl; 1997; 50():107-11. PubMed ID: 9120411
[TBL] [Abstract][Full Text] [Related]
2. Long-term behavioural effects of TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) after subchronic treatment in rats.
Sontag KH; Heim C; Sontag TA; God R; Reichmann H; Wesemann W; Rausch WD; Riederer P; Bringmann G
J Neural Transm Suppl; 1995; 46():283-9. PubMed ID: 8821065
[TBL] [Abstract][Full Text] [Related]
3. The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons.
Bringmann G; God R; Feineis D; Wesemann W; Riederer P; Rausch WD; Reichmann H; Sontag KH
J Neural Transm Suppl; 1995; 46():235-44. PubMed ID: 8821060
[TBL] [Abstract][Full Text] [Related]
4. Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives.
Grote C; Clement HW; Wesemann W; Bringmann G; Feineis D; Riederer P; Sontag KH
J Neural Transm Suppl; 1995; 46():275-81. PubMed ID: 8821064
[TBL] [Abstract][Full Text] [Related]
5. TaClo as a neurotoxic lead: improved synthesis, stereochemical analysis, and inhibition of the mitochondrial respiratory chain.
Bringmann G; God R; Feineis D; Janetzky B; Reichmann H
J Neural Transm Suppl; 1995; 46():245-54. PubMed ID: 8821061
[TBL] [Abstract][Full Text] [Related]
6. Studies of the potentially endogenous toxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) in neuronal and glial cell cultures.
Rausch WD; Abdel-mohsen M; Koutsilieri E; Chan WW; Bringmann G
J Neural Transm Suppl; 1995; 46():255-63. PubMed ID: 8821062
[TBL] [Abstract][Full Text] [Related]
7. [The plasma level of the neurotoxin 1-trichloromethyl-1,2,4,5-tetrahydro-beta-carboline (TaClo) in man after oral administration of chloral hydrate].
Leuschner J; Beuscher N; Zimmermann T; Schürer M; Schulz HU; Jeromin J; Ritter H
Arzneimittelforschung; 1998 Jan; 48(1):1-5. PubMed ID: 9522023
[TBL] [Abstract][Full Text] [Related]
8. 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline, a new inhibitor of complex I.
Janetzky B; God R; Bringmann G; Reichmann H
J Neural Transm Suppl; 1995; 46():265-73. PubMed ID: 8821063
[TBL] [Abstract][Full Text] [Related]
9. Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline.
Sontag TA; Lange KW; Heim C; Kolasiewicz W; Tucha O; Sontag KH
J Neural Transm (Vienna); 2009 Oct; 116(10):1267-71. PubMed ID: 19609633
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of radiolabelled 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a neurotoxic chloral-derived mammalian alkaloid, and its biodistribution in rats.
Bringmann G; Feineis D; Brückner R; God R; Grote C; Wesemann W
Eur J Pharm Sci; 2006 Aug; 28(5):412-22. PubMed ID: 16713202
[TBL] [Abstract][Full Text] [Related]
11. Identification of the dopaminergic neurotoxin 1-trichloromethyl-1,2, 3,4-tetrahydro-beta-carboline in human blood after intake of the hypnotic chloral hydrate.
Bringmann G; God R; Fähr S; Feineis D; Fornadi K; Fornadi F
Anal Biochem; 1999 May; 270(1):167-75. PubMed ID: 10328779
[TBL] [Abstract][Full Text] [Related]
12. Modification of tyrosine hydroxylase activity by chloral derived beta-carbolines in vitro.
Riederer F; Luborzewski A; God R; Bringmann G; Scholz J; Feineis D; Moser A
J Neurochem; 2002 May; 81(4):814-9. PubMed ID: 12065640
[TBL] [Abstract][Full Text] [Related]
13. 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) and related derivatives: chemistry and biochemical effects on catecholamine biosynthesis.
Bringmann G; Feineis D; God R; Peters K; Peters EM; Scholz J; Riederer F; Moser A
Bioorg Med Chem; 2002 Jul; 10(7):2207-14. PubMed ID: 11983518
[TBL] [Abstract][Full Text] [Related]
14. Toxicity and metabolism of the chloral-derived mammalian alkaloid 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) in PC12 cells.
Bringmann G; Feineis D; Münchbach M; God R; Peters K; Peters EM; Mössner R; Lesch KP
Z Naturforsch C J Biosci; 2006; 61(7-8):601-10. PubMed ID: 16989324
[TBL] [Abstract][Full Text] [Related]
15. 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH.
Akundi RS; Macho A; Muñoz E; Lieb K; Bringmann G; Clement HW; Hüll M; Fiebich BL
J Neurochem; 2004 Oct; 91(2):263-73. PubMed ID: 15447660
[TBL] [Abstract][Full Text] [Related]
16. 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) Alters Cell Cycle Progression in Human Neuroblastoma Cell Lines.
Sharma RK; Candelario-Jalil E; Feineis D; Bringmann G; Fiebich BL; Akundi RS
Neurotox Res; 2017 Nov; 32(4):649-660. PubMed ID: 28721631
[TBL] [Abstract][Full Text] [Related]
17. The long-term effects of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) on cognitive performance in rats.
Sontag TA; Lange KW; Heim Ch; Kolasiewicz W; Tucha O; Sontag KH
J Neural Transm Suppl; 2007; (72):149-54. PubMed ID: 17982888
[TBL] [Abstract][Full Text] [Related]
18. Endogenous alkaloids in man. XXXVIII. "Chiral" and "achiral" determination of the neurotoxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) from blood and urine samples by high-performance liquid chromatography--electrospray ionization tandem mass spectrometry.
Bringmann G; Münchbach M; Feineis D; Messer K; Diem S; Herderich M; Clement HW; Stichel-Gunkel C; Kuhn W
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 767(2):321-32. PubMed ID: 11885861
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cells.
Storch A; Hwang YI; Bringmann G; Feineis D; Ott S; Brückner R; Schwarz J
J Neural Transm (Vienna); 2006 Dec; 113(12):1895-901. PubMed ID: 16868795
[TBL] [Abstract][Full Text] [Related]
20. 2,9-Dimethyl-beta-carbolinium, a neurotoxin occurring in human brain, is a potent inducer of apoptosis as 1-methyl-4-phenylpyridinium.
Pavlovic S; Schulze G; Wernicke C; Bonnet R; Gille G; Badiali L; Kaminska A; Lorenc-Koci E; Ossowska K; Rommelspacher H
Neuroscience; 2006; 139(4):1525-37. PubMed ID: 16517085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
